C066-3673 Screening compound: (2E)-3-(4-methoxyphenyl)-N-{9-[(2-methoxyphenyl)amino]-5,6,7,8-tetrahydroacridin-2-yl}prop-2-enamide

C066-3673 Screening compound: (2E)-3-(4-methoxyphenyl)-N-{9-[(2-methoxyphenyl)amino]-5,6,7,8-tetrahydroacridin-2-yl}prop-2-enamide
C066-3673 Screening compound: (2E)-3-(4-methoxyphenyl)-N-{9-[(2-methoxyphenyl)amino]-5,6,7,8-tetrahydroacridin-2-yl}prop-2-enamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C066-3673
(2E)-3-(4-methoxyphenyl)-N-{9-[(2-methoxyphenyl)amino]-5,6,7,8-tetrahydroacridin-2-yl}prop-2-enamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C066-3673

Molecular Formula

C30H29N3O3 (C30 H29 N3 O3)

Compound Name

(2E)-3-(4-methoxyphenyl)-N-{9-[(2-methoxyphenyl)amino]-5,6,7,8-tetrahydroacridin-2-yl}prop-2-enamide

IUPAC name

(2E)-3-(4-methoxyphenyl)-N-{9-[(2-methoxyphenyl)amino]-5678-tetrahydroacridin-2-yl}prop-2-enamide

SMILES

COc1ccc(/C=C/C(Nc(ccc2nc3c4CCCC3)cc2c4Nc(cccc2)c2OC)=O)cc1

InChI

InChI=1S/C30H29N3O3/c1-35-22-15-11-20(12-16-22)13-18-29(34)31-21-14-17-26-24(19-21)30(23-7-3-4-8-25(23)32-26)33-27-9-5-6-10-28(27)36-2/h5-6,9-19H,3-4,7-8H2,1-2H3,(H,31,34)(H,32,33)

InChI Key

WJECGVPVYPMXIQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14715770

Chemical and Physical Properties

Saltdata

HCl

Molecular Weight

479.58

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.779

Distribution Coefficient, logD

5.764

Water Solubility, LogSw

-5.75

Polar Surface Area

54.862

Acid Dissociation Constant (pKa)

12.19

Base Dissociation Constant (pKb)

8.37

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.00

C066-3673 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Human Kinases Annotated Library (2415 compounds)

KRAS-Targeted Library (16000 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with C066-3673 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C066-3673?
Check Price and Availability of C066-3673, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C066-3673 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C066-3673
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C066-3673
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C066-3673 available by request